Regulated  ||| S:0 E:10 ||| VBN
upon  ||| S:10 E:15 ||| IN
activation  ||| S:15 E:26 ||| JJ
normal  ||| S:26 E:33 ||| JJ
T-cell  ||| S:33 E:40 ||| JJ
expressed  ||| S:40 E:50 ||| NN
and  ||| S:50 E:54 ||| CC
secreted  ||| S:54 E:63 ||| NNS
( ||| S:63 E:64 ||| -LRB-
RANTES ||| S:64 E:70 ||| NNP
)  ||| S:70 E:72 ||| -RRB-
and  ||| S:72 E:76 ||| CC
epithelial  ||| S:76 E:87 ||| JJ
cell-derived  ||| S:87 E:100 ||| JJ
neutrophil-activating  ||| S:100 E:122 ||| JJ
peptide  ||| S:122 E:130 ||| NNS
( ||| S:130 E:131 ||| -LRB-
ENA-78 ||| S:131 E:137 ||| NNP
)  ||| S:137 E:139 ||| -RRB-
gene  ||| S:139 E:144 ||| NN
polymorphisms  ||| S:144 E:158 ||| NN
in  ||| S:158 E:161 ||| IN
patients  ||| S:161 E:170 ||| NNS
with  ||| S:170 E:175 ||| IN
biopsy-proven  ||| S:175 E:189 ||| FW
erythema  ||| S:189 E:198 ||| FW
nodosum  ||| S:198 E:207 ||| FW
